Jove
Visualize
联系我们

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA).

Alzheimer's research & therapy·2026
Same author

Spinal cord reserve is associated with multi-dimensional clinical resilience in multiple sclerosis.

Journal of neurology·2026
Same author

Exploring brain-glioma interaction: Effect of neuroligin-3 expression on neurocognitive functioning is independent from epilepsy.

Neuro-oncology advances·2026
Same author

The relationship between objective and subjective cognitive performance and clinical and MRI disease burden in early multiple sclerosis.

Scientific reports·2026
Same author

White Matter Alterations Are More Robust Than Gray Matter Differences in Tinnitus and Hearing Loss: An MRI Study of Military Personnel.

Journal of the Association for Research in Otolaryngology : JARO·2026
Same author

Automatic longitudinal assessment of brain metastases improves detection of disease progression.

Neuro-oncology advances·2026
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Arno Liseune1, Ricardo Magalhães1, Simon Van Eyndhoven1

  • 1Icometrix, Leuven, Belgium.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

针对ARIA检测和分级的自动化软件显示了专家级别的协议. 使用该工具协助放射科医生显著提高了他们对ARIA严重程度的分级能力,帮助治疗决策.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经辐射学神经辐射学
  • 医疗成像中的人工智能
  • 阿尔茨海默病的治疗方法 治疗方法

背景情况:

  • 针对β粉样蛋白的单克隆抗体疗法可以导致ARIA-E () 和ARIA-H (微出血,表面 siderosis).
  • 对临床医生来说,准确地识别和分级ARIA的严重程度是具有挑战性的,影响治疗决策.
  • 辅助自动检测和分级软件可以增强ARIA的放射性评估.

研究的目的:

  • 评估ICOBrain ARIA的性能,这是一个FDA批准的软件,用于ARIA-E和ARIA-H的自动检测和严重程度分级.
  • 为了比较软件和非专家放射科医生 (辅助和无辅助) 与专家神经放射科医生在分级ARIA严重性的协议.

主要方法:

  • 16名非专家放射科医生评估了199名阿尔茨海默病患者用阿杜卡努马布治疗的病例,两次:辅助和无辅助的ICOBrain ARIA.
  • 基础真相 ARIA严重程度是由三个专家神经放射学家为ARIA-E,ARIA-H微出血 (MH) 和ARIA-H表面 siderosis (SS) 建立的.
  • 使用Obuchowski协议度量来比较软件,无助读者和辅助读者与专家的地面真相.

主要成果:

  • ICOBrain ARIA的自动化严重性评级证明了与专家评级的可互换性,实现了与专家间协议相比的协议水平.
  • 与ARIA-E,ARIA-H MH和ARIA-H SS.的无助读数相比,辅助放射科医生与专家的可互换性显著改善 (p<0.05).
  • 软件的协议指标分别为0.853 (ARIA-E),0.805 (ARIA-H MH) 和0.745 (ARIA-H SS),而辅助阅读器则从0.78,0.75,0.66提高到0.83,0.78,0.72分别.

结论:

  • 独立的ICOBrain ARIA软件提供了与专家神经放射学家可比的严重程度分级.
  • 使用ICOBrain ARIA作为辅助工具显著提高了放射科医生对ARIA严重程度的分级能力,从而与专家评估更好地互换.
  • 这种辅助技术有望提高ARIA评估在临床实践中的一致性和准确性.